Therapeutic Area: Metabolic Endocrine

Medroxyprogesterone Acetate

Long acting reversible contraceptive. Contraceptive, adjuvant therapy of endometrial, renal and breast carcinoma.
Composition:

Medroxyprogesterone Acetate 150 mg/ml

Presentation:

1 vial

Route of administration:

Injectable suspension.

Posology:

At the physician’s discretion.

Division:

Ethic | With medical prescription.

Important:

Product imported and distributed by Vincenti International RIF J-501195749.